ArticleTherapeutic advances in medical oncology2024

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations.

Nadia Ghazali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.